Oral Methotrexate Monotherapy for Severe Alopecia Areata: A Single Center Retrospective Case Series.

Misaki Kinoshita-Ise Muskaan SachdevaSylvia A Martinez-CabrialesNeil H ShearPerla Lansang

Published in: Journal of cutaneous medicine and surgery (2021)

Our results support MTX monotherapy as a feasible option for severe AA patients who fail other standard therapies or for whom systemic corticosteroids are contraindicated.

Keyphrases

combination therapy
early onset
open label
drug induced
cross sectional
randomized controlled trial
low dose